RxDoctor Payments Data

Claire Kaufman, MD

Vascular & Interventional Radiology · Portland, ORNPI 1356630073

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,250 of the $3,003 with a category attached, or 74.9%. Medtronic accounts for 80.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $2,590 and has fallen 95.9% since, to $106 in 2025.

$3,003in general payments, 2019–2025

Across 11 payments — averaging $272.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Penumbra, Inc.$248
  • Inari Medical, Inc.$150
  • Boston Scientific$106
  • Stryker$48
  • Sirtex Medical Inc$42
$121,329in research payments, 2019–2025

Across 12 payments — averaging $10,111 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$121K

What the payments were for

  • Speaking & faculty fees$2,25075%
  • Food & beverage$75325%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,003 in reported general payments places this provider in the 60th percentile of 73 vascular & interventional radiology providers in Oregon.

See all vascular & interventional radiology providers in Oregon

Medicare billing

Part B allowed, 2024
$32,531
Medicare patients
94
Services billed
298

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →